Cite
HARVARD Citation
Al-Janabi, A. et al. (2020). Update on risankizumab for the treatment of moderate to severe psoriasis. Expert opinion on biological therapy. pp. 1245-1251. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Al-Janabi, A. et al. (2020). Update on risankizumab for the treatment of moderate to severe psoriasis. Expert opinion on biological therapy. pp. 1245-1251. [Online].